- GlobeNewswire•12 days agoKamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
NESS ZIONA, Israel, Feb. 08, 2017-- Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announced today the appointment of Gwen A. Melincoff to the Company’ s Board ...
- Associated Press•14 days ago
The Ness Ziona, Israel-based company said it had a loss of 5 cents per share. The biopharmaceutical posted revenue of $24.3 million in the period. For the year, the company reported that its loss narrowed ...
- GlobeNewswire•14 days ago
Total revenues for 2016 were $77.5 million, an 11% increase over 2015. Full year 2016 Proprietary Product revenues up over 30%. Reaffirms revenue guidance of $100 million for 2017.
KMDA.TA : Summary for KAMADA ORD ILS1.00 - Yahoo Finance
Kamada Ltd. (KMDA.TA)
Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
|Bid||2,622.00 x 346500|
|Ask||2,631.00 x 57900|
|Day's Range||2,600.00 - 2,636.00|
|52 Week Range||13.50 - 2,636.00|
|PE Ratio (TTM)||-14,189.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|